全球植入式帮浦市场

到 2030 年，全球植入式帮浦市场规模将达到 247 亿美元

全球植入式帮浦市场规模预计在2024年为195亿美元，到2030年将达到247亿美元，在2024-2030年的分析期间内，复合年增长率为4.0%。病患自控疼痛帮浦是本报告分析的细分市场之一，预计其复合年增长率为3.2%，到分析期结束时规模将达到86亿美元。肠内帮浦细分市场在分析期间的复合年增长率预计为4.0%。

美国市场规模估计为 53 亿美元，中国市场预期复合年增长率为 7.2%

美国植入式帮浦市场规模预计2024年达到53亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到50亿美元，2024年至2030年的复合年增长率为7.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为1.7%和3.1%。在欧洲，预计德国的复合年增长率为2.3%。

全球植入式帮浦市场－主要趋势与驱动因素摘要

为什么植入式帮浦对于长期药物传输至关重要？

植入式帮浦已成为一种精确控制的装置，用于为慢性疾病患者提供长期持续的药物输送。这些系统透过手术植入并进行编程，将目标剂量直接输送到体腔、腹腔或血流等体腔内。它们主要用于疼痛管理、痉挛治疗、化疗和荷尔蒙补充疗法。与体外帮浦不同，植入式系统可降低感染风险，提高患者遵从性，并提供稳定的药物血浆浓度，同时最大限度地减少全身暴露。

对于患有严重慢性疼痛或痉挛且对口服药物无反应的患者，可以透过植入式帮浦进行鞘内给药，从而实现低剂量局部治疗。同样，正在接受化疗的癌症患者可以透过标靶输注避免反覆就诊，并降低毒性。随着全球癌症、神经系统疾病和末期器官疾病负担的增加，对稳定、患者友善的药物传递机制的需求必将增长。

科技如何改善帮浦的功能和临床结果？

技术进步提高了泵浦的安全性、可编程性和电池寿命。最新的植入式帮浦具有可程式设计剂量、可再填充储液器和无线远端检测等功能，使临床医生能够非侵入性地调整输液参数。低功耗电子设备和智慧软体可即时监测药物流速、储液器容量和压力的变化，从而延长了电池寿命。这些功能减少了维护工作量，并改善了长期临床疗效。

用于泵浦製造的材料正在不断发展，以提高生物相容性并降低感染风险。新的导管设计提高了液体稳定性，并最大限度地减少了堵塞和洩漏。整合远端检测的智慧型帮浦现在可以远端监控帮浦的性能，帮助临床医生及早发现故障并根据需要调整治疗方案。与电子健康记录(EMR) 和安全程式设计平台的整合简化了资料追踪和治疗方案的客製化。

需求成长的领域和主要临床应用有哪些？

疼痛管理、肿瘤科、内分泌科和神经科对植入式帮浦的需求日益增长。患有腰椎手术失败症候群和癌症相关疼痛的慢性疼痛患者在植入式帮浦使用者中占了很大一部分。鞘内Baclofen帮浦用于治疗痉挛，尤其是脑性麻痹和多发性硬化症患者，显着改善了患者的生活品质。在肿瘤科，它们越来越多地用于腹膜化疗以及胃肠道和肝臟恶性肿瘤的局部给药。

内分泌学市场也不断扩张，尤其是在需要荷尔蒙替代治疗和长期输注某些化合物的疾病领域。在小儿科中，某些神经系统疾病的植入式治疗应用日益增多，而移植系统也正被考虑用于为移植患者输送免疫抑制剂。由于完善的报销框架和专业的外科手术经验，北美和欧洲的成长最为显着；而随着医疗基础设施的改善，亚太地区和拉丁美洲的植入式治疗应用也逐渐增加。

是什么推动了植入式帮浦市场的成长？

植入式帮浦市场的成长受到多种因素的推动，包括慢性疼痛和神经系统疾病盛行率的上升、对长效、特异性给药的需求不断增长，以及设备可靠性和微型化的不断改进。生物相容性材料、电池系统和可程式设计软体的进步，使泵浦的性能更加安全高效。併发症率的降低和患者依从性的提高，正在推动其在医院和门诊医疗机构的普及。

肿瘤中心、神经科诊所和疼痛管理诊所等终端应用领域的不断扩张，推动了手术量的增长以及对维护和补充服务的需求。整合远端检测和电子病历 (EMR) 相容性可支援长期患者监测和个人化治疗。人口老化、癌症发生率上升以及对微创治疗方案的投资不断增加，为市场成长创造了有利条件。这些发展使植入式帮浦成为慢性病管理、精准医疗和先进医疗服务的重要工具。

部分

产品类型（病患控制镇痛帮浦、肠内帮浦、胰岛素帮浦、弹性帮浦、其他产品类型）、应用（肿瘤学应用、小儿科/新生儿学应用、胃肠科应用、血液学应用、其他应用）、最终用途（医院/诊所最终用途、门诊手术中心最终用途、家庭医疗保健最终用途）

受访公司范例

• Abbott Laboratories
• AngioDynamics
• B. Braun Melsungen AG
• Baxter International Inc.
• BD（Becton, Dickinson & Co.）
• Boston Scientific Corporation
• CareFusion（now part of BD）
• Cognos Therapeutics Inc.
• Debiotech SA
• Flowonix Medical Inc.
• Fresenius Kabi AG
• Hospira（subsidiary of Pfizer）
• Insulet Corporation
• Johnson & Johnson
• Medtronic plc
• MOOG Inc.
• Smiths Medical
• Terumo Corporation
• tricumed Medizintechnik GmbH
• Zealand Pharma（affiliate in pumps）

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Implantable Pumps Market to Reach US$24.7 Billion by 2030

The global market for Implantable Pumps estimated at US$19.5 Billion in the year 2024, is expected to reach US$24.7 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Patient-Controlled Analgesia Pump, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Enteral Pump segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.3 Billion While China is Forecast to Grow at 7.2% CAGR

The Implantable Pumps market in the U.S. is estimated at US$5.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Implantable Pumps Market - Key Trends & Drivers Summarized

Why Are Implantable Pumps Becoming Integral to Long-Term Drug Delivery?

Implantable pumps are gaining prominence as precision-controlled devices for long-term, continuous drug delivery in patients with chronic conditions. These systems are surgically implanted and programmed to deliver targeted doses directly into body compartments such as the intrathecal space, peritoneal cavity, or bloodstream. They are primarily used in pain management, spasticity, chemotherapy, and hormone replacement therapy. Unlike external pumps, implantable systems reduce infection risks, improve patient compliance, and provide steady drug plasma levels with minimal systemic exposure.

Patients with severe chronic pain or spasticity who do not respond well to oral medications benefit from intrathecal drug delivery through implantable pumps, which offer localized treatment at lower doses. Similarly, cancer patients undergoing continuous chemotherapy can avoid repeated hospital visits and reduce toxicity through targeted infusion. As the global burden of cancer, neurological disorders, and end-stage organ diseases increases, the need for stable and patient-friendly drug delivery mechanisms is rising steadily.

How Is Technology Enhancing Pump Functionality and Clinical Outcomes?

Technological advancements are improving pump safety, programmability, and battery longevity. Modern implantable pumps include features such as programmable dosing, refillable reservoirs, and wireless telemetry that allow clinicians to adjust infusion parameters non-invasively. Battery life is being extended through low-power electronics and intelligent software that monitors drug flow, reservoir volume, and pressure changes in real time. These features reduce maintenance frequency and improve long-term clinical outcomes.

Materials used in pump construction are evolving to enhance biocompatibility and reduce infection risk. New catheter designs are improving fluid stability and minimizing occlusions or leakage. Smart pumps with telemetry integration are allowing remote monitoring of pump performance, helping clinicians detect malfunctions early and adjust therapy as needed. Integration with electronic medical records (EMRs) and secure programming platforms is streamlining data tracking and therapy customization.

Where Is Demand Growing, and What Are the Key Clinical Applications?

Demand for implantable pumps is growing across pain management, oncology, endocrinology, and neurology. Chronic pain patients with failed back surgery syndrome or cancer-related pain represent a significant portion of implantable pump users. In spasticity treatment, particularly for individuals with cerebral palsy or multiple sclerosis, intrathecal baclofen pumps offer substantial improvement in quality of life. Oncology use is expanding for peritoneal chemotherapy and regional drug delivery in gastrointestinal and hepatic malignancies.

The market is also expanding in endocrinology, particularly for conditions requiring hormone replacement or long-term infusion of specific compounds. Pediatric use is increasing in select neurological conditions, and transplant patients are being considered for immunosuppressive drug delivery via implantable systems. Growth is most prominent in North America and Europe due to established reimbursement frameworks and specialized surgical expertise, but adoption is gradually rising in Asia Pacific and Latin America as healthcare infrastructure improves.

What Is Driving Growth in the Implantable Pumps Market?

Growth in the implantable pumps market is driven by several factors including rising prevalence of chronic pain and neurological disorders, increased demand for long-duration, site-specific drug delivery, and continuous improvements in device reliability and miniaturization. Advancements in biocompatible materials, battery systems, and programmable software are enabling safer and more efficient pump performance. Reduced complication rates and better patient adherence are reinforcing adoption in both hospital-based and outpatient care settings.

End-use expansion across oncology centers, neurology clinics, and pain management practices is increasing procedure volumes and driving demand for maintenance and refill services. Integration of telemetry and EMR compatibility is supporting long-term patient monitoring and therapeutic customization. Aging populations, rising cancer incidence, and increased investment in minimally invasive treatment options are creating favorable conditions for market growth. These developments are positioning implantable pumps as essential tools in chronic disease management, precision medicine, and advanced care delivery.

SCOPE OF STUDY:

The report analyzes the Implantable Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump, Other Product Types); Application (Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application, Hematology Application, Other Applications); End-Use (Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use, Home Healthcare End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Abbott Laboratories
• AngioDynamics
• B. Braun Melsungen AG
• Baxter International Inc.
• BD (Becton, Dickinson & Co.)
• Boston Scientific Corporation
• CareFusion (now part of BD)
• Cognos Therapeutics Inc.
• Debiotech SA
• Flowonix Medical Inc.
• Fresenius Kabi AG
• Hospira (subsidiary of Pfizer)
• Insulet Corporation
• Johnson & Johnson
• Medtronic plc
• MOOG Inc.
• Smiths Medical
• Terumo Corporation
• tricumed Medizintechnik GmbH
• Zealand Pharma (affiliate in pumps)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Implantable Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Chronic Diseases Throws the Spotlight on Implantable Pumps for Targeted Drug Delivery
  • Growing Incidence of Cancer and Severe Pain Conditions Spurs Demand for Intrathecal and Chemotherapy Infusion Systems
  • Advancements in Miniaturization and Biocompatible Materials Strengthen the Business Case for Next-Gen Implantable Pumps
  • Aging Global Population and Increasing Comorbidities Expand Addressable Market for Long-Term Drug Delivery Devices
  • Patient Preference for Reduced Hospital Visits and Home-Based Therapies Drives Adoption of Implantable Pump Solutions
  • Clinical Benefits of Continuous and Programmable Infusion Accelerate Use in Pain Management and Neurological Disorders
  • Integration with Wireless Monitoring and Smart Control Systems Enhances Safety and Treatment Precision
  • Innovation in Closed-Loop and Responsive Drug Delivery Systems Boosts Demand for Intelligent Implantable Pumps
  • Increased Use in Pediatric and Rare Disease Treatment Supports Niche Application Growth
  • Surge in Research on Biodegradable and Rechargeable Implants Fuels Development of Next-Generation Devices
  • Growing Investment in Personalized and Precision Medicine Aligns with Programmable Infusion Technologies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Implantable Pumps Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Implantable Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Patient-Controlled Analgesia Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Patient-Controlled Analgesia Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Patient-Controlled Analgesia Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Enteral Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Enteral Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Enteral Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Insulin Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Insulin Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Insulin Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Elastomeric Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Elastomeric Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Elastomeric Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pediatrics / Neonatology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Pediatrics / Neonatology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Pediatrics / Neonatology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Gastroenterology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Gastroenterology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Gastroenterology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hematology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hematology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Hematology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Home Healthcare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Home Healthcare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Home Healthcare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: China 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Implantable Pumps by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Europe 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: France 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Germany 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Italy 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: UK 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Spain 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Russia 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Implantable Pumps by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Australia 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: India 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: South Korea 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Implantable Pumps by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Latin America 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Argentina 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Brazil 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Mexico 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Implantable Pumps by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Middle East 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Iran 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Israel 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: UAE 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Africa 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION